ntists show children of older fathers face a higher risk of a type of lymphoma

Scientists show children of older fathers face a higher risk of a type of lymphoma


By Wayne Lewis


Risk of non-Hodgkin’s lymphoma is higher for children of older men, according to City of Hope researchers — a finding that adds to a growing body of evidence suggesting that men, too, may have a biological clock.

The study is one of the first to examine the relationship between parents’ age and their adult offspring’s likelihood of facing cancers of the blood and immune system. Yani Lu, Ph.D., a postdoctoral fellow in the Division of Cancer Etiology, led the study, which was released online in the American Journal of Epidemiology on June 3.

Yani Lu (Photo by p.cunningham)

“As a man, you may think, ‘I can have a baby at 50 or 60 and live long enough to see him go through college.’ But there may be other risks for your child down the line, and you may want to be conscious of those risks,” said Lu.

Lu’s research drew upon data from the California Teachers Study. Initiated in 1995, this project tracks the health, lifestyle choices and demographic information of nearly 133,500 female teachers and administrators in the California public schools’ retirement system. The teachers study is led by Leslie Bernstein, Ph.D., director of the Division of Cancer Etiology in the Department of Population Sciences and Lu’s mentor.

In the latest project, researchers focused on 110,999 women, 819 of whom had been diagnosed with a hematological malignancy. The study revealed that participants born to fathers older than age 40 faced a 59 percent greater risk of non-Hodgkin’s lymphoma compared to similar women born to fathers younger than 25.

“For adult-onset malignancies, people seldom think back” to factors early in life, Lu said. “Diagnosis for non-Hodgkin’s lymphoma occurs closer to the age of 70, so why would in utero factors be related to risk?”

In the study, the fathers’ age had no effect on risk for acute myeloid leukemia or multiple myeloma. Maternal age did not significantly influence risk for blood cancers.

Science has shown that the ticking biological clock is associated with a higher incidence of health issues in children of older mothers. These women face greater risk of miscarriage and increased risks of bearing children with low birth weight or serious health issues such as Down’s syndrome. A recent, large study suggested that children of women over 40 have a greater chance of having autism.

Similar findings among older fathers are scanty, although research going back almost 100 years suggests that these men are more likely to produce children with certain rare birth defects. Numerous studies also show that offspring of older men have a greater risk of developing schizophrenia.

As Lu noted, however, a burgeoning field of research suggests a father’s age at conception may play a more significant role in his progeny’s health than once thought. Recent investigations indicate that children of older fathers have a greater chance of prostate and breast cancers in adulthood as well as some blood cancers during childhood.

Lu believes the male biological clock might relate to mutations that can accumulate in a man’s reproductive cells over the course of a lifetime. Such cells divide more rapidly than a woman’s reproductive cells. More divisions lead to more chances for abnormalities to arise.

Older parental age also appears to be associated with longer length of offspring’s telomeres, the end caps on chromosomes, which might be linked to non-Hodgkin’s lymphoma risk, Lu suggested.

Because non-Hodgkin’s lymphoma is actually a cluster of related diseases with about 30 subtypes, Lu plans to examine how paternal age and other health factors during the early years of life influence risk for specific disease subtypes.

Sophia S. Wang, Ph.D., associate professor of population sciences, was the paper’s senior author. The National Institutes of Health and the California Breast Cancer Research Fund funded the research.

Search


Information by Disease ------------------- Bile duct cancer Bladder cancer Bone cancer Brain tumors Breast cancer Cervical cancer Colon Cancer/Colorectal Cancer Diabetes, Endocrinology and Metabolism Endometrial/uterine cancer Esophageal cancer Gallbladder cancer Gastric (Stomach) cancer Gastrointestinal cancers Gastrointestinal carcinoid tumors Gynecologic cancers Head and neck cancers Kidney/Renal Cell Cancer Leukemia Leukemia, acute lymphoblastic Leukemia, acute myeloid Leukemia, adult T-cell Leukemia, chronic lymphocytic Leukemia, chronic myelogenous Leukemia, hairy cell Liver cancer Lung cancer Lymphoma Lymphoma, Hodgkin's Lymphoma, Non-Hodgkin’s Melanoma Multiple Myeloma Musculoskeletal tumors Myelodysplasia Neuroblastoma Neuro-oncology Ovarian cancer Pancreatic cancer Paranasal sinus and nasal cavity cancers Parathyroid cancer Pediatric cancers Pharyngeal (throat) cancer Pituitary tumors Prostate cancer Rectal cancer/Colorectal cancer Salivary gland cancer Skin cancer Small intestine cancer Soft tissue sarcoma Spine tumors Testicular Cancer Thyroid cancer Urologic Cancers
Advanced Search Options
News & Publications Search


printemail


© 2009 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673) City of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness. City of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...